Rubicon moment for Australian medicines

By Megan Brodie 2 years ago | In Industry
  • 2 years ago
BMS GM Neil MacGregor joined Janssen MD Biljana Naumovic and oncologist Dr John Zalcberg at CanForum 2021.

29 November 2021 “2022 is going to be a watershed year,” Rare Cancers Australia CEO…

This is subscriber-only content. Please login to continue reading.